Literature DB >> 8471195

Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand.

C P Pau1, S Lee-Thomas, W Auwanit, J R George, C Y Ou, B S Parekh, T C Granade, D L Holloman, S Phillips, G Schochetman.   

Abstract

OBJECTIVE: To develop and evaluate a simple V3 peptide-based enzyme immunoassay (EIA) for large-scale serotyping of HIV-1 specimens from Thailand.
DESIGN: Serologic reactivities with synthetic peptides derived from the V3 loop of gp120 were used for typing HIV-1 specimens.
METHODS: Synthetic peptides PND-A and PND-B, derived from the consensus amino-acid sequences of the V3 loop of gp120 from two major genomic variants of HIV-1 in Thailand (A and B), were evaluated in an EIA on 61 Thai HIV-1 sera for which genotypes had been determined by polymerase chain reaction. The peptide EIA was then applied to sera from 188 HIV-1-infected patients, selected in non-random, convenience samples of known risk groups from four geographic regions of Thailand.
RESULTS: The sensitivities and specificities of PND-A and PND-B were 86% (30 out of 35) and 96% (25 out of 26) and 92% (24 out of 26) and 94% (33 out of 35), respectively, with 100% predictive values of a monoreactive positive test for both peptides. The assay classified 101 specimens as serotype A, 39 as serotype B, eight as serotype AB (dually reactive), and 40 as untypable (non-reactive). Excluding dual reactors and non-reactors, 92% (77 out of 84) of specimens from patients probably infected by sexual contact were serotype A; conversely, 76% (28 out of 37) of injecting drug users were serotype B.
CONCLUSION: The serologic results corroborated previous findings, in a smaller subset of samples, of an apparent segregation of viral subtypes by mode of transmission, suggesting two separate HIV-1 epidemics in Thailand. This peptide EIA could be a valuable epidemiologic tool in determining the dynamics of the rapid spread of HIV-1 in Thailand.

Entities:  

Keywords:  Asia; Behavior; Developing Countries; Diseases; Drug Usage; Epidemics; Examinations And Diagnoses; Hiv Infections; Hiv Serodiagnosis; Homosexuals; Iv Drug Users; Laboratory Examinations And Diagnoses; Measurement; Prostitutes; Reliability; Research Methodology; Sex Behavior; Southeastern Asia; Thailand; Validity; Viral Diseases

Mesh:

Substances:

Year:  1993        PMID: 8471195     DOI: 10.1097/00002030-199303000-00005

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  22 in total

1.  Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection.

Authors:  T J Spira; L Lam; S C Dollard; Y X Meng; C P Pau; J B Black; D Burns; B Cooper; M Hamid; J Huong; K Kite-Powell; P E Pellett
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  The Honduran human immunodeficiency virus type 1 (HIV-1) epidemic is dominated by HIV-1 subtype B as determined by V3 domain sero- and genotyping.

Authors:  C Lara; M Sällberg; B Johansson; I L de Rivera; A Sönnerborg
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 3.  Recurrent CDC group IVc-2 bacteremia in a human with AIDS.

Authors:  R R Anderson; P Warnick; P C Schreckenberger
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies.

Authors:  J P Moore; F E McCutchan; S W Poon; J Mascola; J Liu; Y Cao; D D Ho
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B.

Authors:  J P Moore; A Trkola; B Korber; L J Boots; J A Kessler; F E McCutchan; J Mascola; D D Ho; J Robinson; A J Conley
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

6.  Subtyping of human immunodeficiency virus type 1 strains by using antibodies specific for the third variable domain (V3) of gp120: results may be affected by divergent V3 sequences.

Authors:  K Sherefa; M Sällberg; B Johansson; M Salminen; A Sönnerborg
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

7.  Unusually high seroprevalence of Borna disease virus in clade E human immunodeficiency virus type 1-infected patients with sexually transmitted diseases in Thailand.

Authors:  W Auwanit; P I Ayuthaya; T Nakaya; S Fujiwara; T Kurata; K Yamanishi; K Ikuta
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

8.  p24 Antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection.

Authors:  Ruengpung Sutthent; Narintorn Gaudart; Kulkanya Chokpaibulkit; Nattaya Tanliang; Chinda Kanoksinsombath; Pongsakdi Chaisilwatana
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

9.  Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein.

Authors:  C P Pau; L L Lam; T J Spira; J B Black; J A Stewart; P E Pellett; R A Respess
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolates.

Authors:  R Q Warren; M T Wong; G P Melcher; S P Blatt; P Cahn; H Perez; I Zapiola; M B Bouzas; G Muchinik; S A Anderson
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.